SX Congress USA is where biotech companies from emerging startups to later-stage firms meet investors and pharma partners to power the next stage of growth. Attendees engage in 1:1 partnering, focused discussions on capital raising, investment strategies, commercialisation and pharma partnerships in the US life sciences sector. With tailored tracks, network…
— and 129 more, by name unsung —
- Understanding what biotech investors prioritize when evaluating Seed and Series A funding opportunities - Effectively communicate your vision and scientific potential to attract …
South Florida is solidifying its position as a national healthcare and life sciences hub. With its strategic location, growing infrastructure, and influx of investment, the city is…
- Crafting a compelling value proposition that resonates with investors - Understanding the unique funding challenges in the medtech sector - Preparing for regulatory hurdles that …
Is your company’s intellectual property pieces of paper you pray never get a close look, or is it the true crown jewel of your business? This masterclass will address how biotechno…
- Which markets are currently most desirable for startups and why? - Navigating varied and complex regulatory requirements across China, Europe, and the Middle East - Discussing th…
What does it mean when 209 companies show up — and 2 bet on three roles at once?
The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.
The Triple-Threat
86% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.
Of 151 on the bill · classified by free-text title
These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.